Answer ALS Launches AI Drug Development Collaboration with GATC Health, Pennington Biomedical Research Center, and Tulane to Advance ALS Treatment Discovery
NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health — a…


Data & Technology
Multi-Omnics Analysis
IPS Cells & Motor Neurons
Clinic & enrollment